Carolinas HealthCare System Center for Liver Disease — Charlotte, North Carolina

Carolinas HealthCare System Center for Liver Disease is a clinical research site located in Charlotte, North Carolina, United States 28204.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

Carolinas HealthCare System Center for Liver Disease has participated in 4 clinical trials.

Therapeutic areas: Hepatitis C, Hepatocellular Carcinoma, Decompensated Cirrhosis.

Sponsors: Target PharmaSolutions, Inc., Conatus Pharmaceuticals Inc., Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charlotte

Browse all research sites in North Carolina · View every site in Charlotte

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carolinas HealthCare System Center for Liver Disease?

Carolinas HealthCare System Center for Liver Disease has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carolinas HealthCare System Center for Liver Disease conducted?

Carolinas HealthCare System Center for Liver Disease has 4 clinical trials on record. Their work covers Hepatitis C, Hepatocellular Carcinoma, Decompensated Cirrhosis.

Is Carolinas HealthCare System Center for Liver Disease accredited by Crixeo Clinical Trials?

Carolinas HealthCare System Center for Liver Disease has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carolinas HealthCare System Center for Liver Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.